Endomyocardial biopsy in patients with myocarditis—still justified in the CMR era? A single-centre experience
Due to a high therapeutic yield for initiation of immunosuppressive therapy in non-infectious myocarditis, performing EMB should be considered in all high-risk patients. In patients without clinical risk factors including cases of recurrent or relapsing myocarditis no specific therapy was initiated.
Authors
- Ute Mons (ORCID: https://orcid.org/0000-0003-1764-6783)
- Lenhard Pennig (ORCID: https://orcid.org/0000-0002-6606-9313)
- Roman Pfister (ORCID: https://orcid.org/0000-0002-4358-5008)
- Karin Klingel (ORCID: https://orcid.org/0000-0003-0203-2498)
- Henrik ten Freyhaus
- Katharina Seuthe (ORCID: https://orcid.org/0000-0002-6346-7500)
Institutions
- University of Cologne (DE)
- University Children's Hospital Tübingen (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1007/s00392-024-02574-4
- Citations
- 2
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Universitätsklinikum Köln